about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More
1.32
0.02
(1.54%)
15,517
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
VivoSim Labs Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..